• Integrated Kidney Care of Great Plains, LLC

    KCE Located In: Iowa and Nebraska

  • Integrated Kidney Care of Great Plains, LLC

    KCE Located In: Iowa and Nebraska

Participant Groups and Providers

IOWA KIDNEY PHYSICIANS, P.C.

ARANI NANAVATI

CANDICE GRUSS

DHIVYA SUNDARAMURTHY

IVY MELGAREJO

JANA VAN HAAFTEN

JENNIFER THOMPSON

JESSICA MATHISEN

JESSICA SCHAACK

JOHANN SCHMOLCK

KANWALJIT CHOUHAN

MARK BELZ

SAMEER YASEEN

LINCOLN NEPHROLOGY & HYPERTENSION PC

ELIZABETH CARTHEL

JENNIFER AXT

LESLIE SPRY

MARY CHURCHILL

MATTHEW GLATHAR

MICHAEL AARONSON

RACHEL BROCK

RUGMINI WARRIER

SANDRA LLOYD

SARA KLEIN

SON TRAN

STEPHANIE FOSTER

YIFEI ZHANG

OMAHA NEPHROLOGY PC

DAVID GOLDNER

HEATHER LECHNOWSKY

JEREMY PEPIN

JOSEPH BAST

JUDD BAUER

RICHARD LUND

SONALI DESHMUKH

Preferred Groups and Providers

VILLAGEHEALTH DM LLC

Governing Body Designees

Mark Belz
Iowa Kidney Physicians

Joseph Bast
Omaha Nephrology PC

Aaron Blass
Davita IKC

Dawn Ericson
Davita IKC

Matt Glathar
Lincoln Nephrology and Hypertension

Stephen Steininger
Consumer Advocate

Clinical and Administrative Leadership

Aaron Blass
Primary Contact & Administrative Leader
Director, DaVita IKC

Joseph Bast
KCE Clinical Leader
Omaha Nephrology PC

Quality Measures

Information for the following performance measures will be available by February 1st, 2024.

  • The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
  • The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
  • Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.

Shared Savings and Losses

Information for the following performance measures will be available by February 1st, 2024.

  • Total amount of Shared Savings or Shared Losses per Performance Year
  • Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
  • Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, click here.